PF374 IBRUTINIB PLUS FLUDARABINE, CYCLOPHOSPHAMIDE, AND RITUXIMAB (IFCR) AS INITIAL THERAPY FOR YOUNGER PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE-ARM, MULTICENTER, PHASE 2 TRIAL

Journal article

Peer reviewed

M.S. Davids, D.M. Brander, H.T. Kim, S. Tyekucheva, J. Bsat, A. Savell, J.M. Hellman, J. Bazemore, K. Francoeur, A. Alencar, …

HemaSphere, Vol.3(S1), pp.138-139

2019-06

Metrics

6 Record Views

Title: PF374 IBRUTINIB PLUS FLUDARABINE, CYCLOPHOSPHAMIDE, AND RITUXIMAB (IFCR) AS INITIAL THERAPY FOR YOUNGER PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE-ARM, MULTICENTER, PHASE 2 TRIAL
Creators: M.S. Davids
D.M. Brander
H.T. Kim
S. Tyekucheva
J. Bsat
A. Savell
J.M. Hellman
J. Bazemore
K. Francoeur
A. Alencar
L. Shune
M. Omaira
C.A. Jacobson
P. Armand
S. Ng
J. Crombie
A.S. LaCasce
J. Arnason
E.P. Hochberg
R.W. Takvorian
J.S. Abramson
D.C. Fisher
J.R. Brown
Publication Details: HemaSphere, Vol.3(S1), pp.138-139
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031714382402976